• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prevalence of 185delAG and 5382insC mutations in BRCA1, and 6174delT in BRCA2 in women of Ashkenazi Jewish origin in southern Brazil.在巴西南部的阿什肯纳兹犹太裔女性中,BRCA1 中的 185delAG 和 5382insC 突变,以及 BRCA2 中的 6174delT 的发生率。
Genet Mol Biol. 2012 Jul;35(3):599-602. doi: 10.1590/S1415-47572012000400009. Epub 2012 Aug 17.
2
Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.阿什肯纳兹犹太人群中BRCA1和BRCA2常见突变的频率。
Nat Genet. 1996 Oct;14(2):185-7. doi: 10.1038/ng1096-185.
3
The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.在阿什肯纳兹女性中,BRCA1基因的185delAG和5382insC以及BRCA2基因的6174delT这几种始祖突变出现在60%的卵巢癌患者和30%的早发性乳腺癌患者中。
Am J Hum Genet. 1997 Mar;60(3):505-14.
4
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.在德系犹太人个体中,BRCA2基因6174delT突变的携带频率约为1%。
Nat Genet. 1996 Oct;14(2):188-90. doi: 10.1038/ng1096-188.
5
Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors.交界性卵巢肿瘤中BRCA1和BRCA2基因的犹太祖先突变率。
J Natl Cancer Inst. 1998 Jul 1;90(13):995-1000. doi: 10.1093/jnci/90.13.995.
6
Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.患有前列腺癌的德系犹太人男性中BRCA1基因185delAG突变及BRCA2基因6174delT突变的缺失情况
Br J Cancer. 1998 Sep;78(6):771-3. doi: 10.1038/bjc.1998.576.
7
Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients.阿什肯纳兹犹太乳腺癌患者中常见BRCA1和BRCA2突变的频率及携带者风险。
Am J Hum Genet. 1998 Jul;63(1):45-51. doi: 10.1086/301903.
8
Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.在患有前列腺癌的加拿大德系犹太人男性中,BRCA1/2基因的始祖突变并不常见。
BMC Med Genet. 2003 Aug 11;4:7. doi: 10.1186/1471-2350-4-7.
9
Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.以色列德系犹太人中BRCA1和BRCA2基因的始祖突变:卵巢癌及卵巢癌-乳腺癌家族中的突变频率及差异外显率
Am J Hum Genet. 1997 May;60(5):1059-67.
10
Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.对患有家族性乳腺癌和卵巢癌的德系犹太及非德系犹太女性的BRCA1和BRCA2进行突变分析。
Hum Mutat. 2000 Dec;16(6):491-501. doi: 10.1002/1098-1004(200012)16:6<491::AID-HUMU6>3.0.CO;2-J.

引用本文的文献

1
Mutational spectrum and profile of breast and ovarian cancer patients in Saudi Arabia's western region: single center experience.沙特阿拉伯西部地区乳腺癌和卵巢癌患者的突变谱及特征:单中心经验
Discov Oncol. 2025 May 20;16(1):829. doi: 10.1007/s12672-025-02640-x.
2
Landscape of germline variants in breast and ovarian cancer in Peru.秘鲁乳腺癌和卵巢癌种系变异情况
Front Oncol. 2023 Aug 17;13:1227864. doi: 10.3389/fonc.2023.1227864. eCollection 2023.
3
Population-based screening of Uruguayan Ashkenazi Jews for recurrent BRCA1 and BRCA2 pathogenic sequence variants.对乌拉圭阿什肯纳兹犹太人进行基于人群的BRCA1和BRCA2复发性致病序列变异筛查。
Mol Genet Genomic Med. 2022 Jun;10(6):e1928. doi: 10.1002/mgg3.1928. Epub 2022 Mar 25.
4
Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa.北非乳腺癌和卵巢癌中 BRCA 基因的特定和复发/起始致病性变异的流行率。
BMC Cancer. 2022 Feb 25;22(1):208. doi: 10.1186/s12885-022-09181-4.
5
Advanced Approaches to Breast Cancer Classification and Diagnosis.乳腺癌分类与诊断的先进方法
Front Pharmacol. 2021 Feb 26;11:632079. doi: 10.3389/fphar.2020.632079. eCollection 2020.
6
Germline mutational spectrum in Armenian breast cancer patients suspected of hereditary breast and ovarian cancer.疑似遗传性乳腺癌和卵巢癌的亚美尼亚乳腺癌患者的种系突变谱
Hum Genome Var. 2021 Feb 9;8(1):9. doi: 10.1038/s41439-021-00140-2.
7
Identification of Mutation in Exon11 of BRCA1 Gene in Bangladeshi Patients with Breast Cancer.孟加拉国乳腺癌患者BRCA1基因第11外显子突变的鉴定
Asian Pac J Cancer Prev. 2019 Nov 1;20(11):3515-3519. doi: 10.31557/APJCP.2019.20.11.3515.
8
Landscape of Germline Mutations in DNA Repair Genes for Breast Cancer in Latin America: Opportunities for PARP-Like Inhibitors and Immunotherapy.拉美乳腺癌中 DNA 修复基因种系突变的全景:PARP 抑制剂和免疫疗法的机会。
Genes (Basel). 2019 Oct 10;10(10):786. doi: 10.3390/genes10100786.
9
BRCA1 c.68_69delAG (exon2), c.181T>G (exon5), c.798_799delTT and 943ins10 (exon11) mutations in Burkina Faso.布基纳法索BRCA1基因的c.68_69delAG(外显子2)、c.181T>G(外显子5)、c.798_799delTT和943ins10(外显子11)突变。
J Public Health Afr. 2018 Jul 6;9(1):663. doi: 10.4081/jphia.2018.663. eCollection 2018 May 21.
10
Clusters of genetic diseases in Brazil.巴西的遗传性疾病集群。
J Community Genet. 2019 Jan;10(1):121-128. doi: 10.1007/s12687-018-0369-1. Epub 2018 Jun 2.

本文引用的文献

1
Absence of founder BRCA1 and BRCA2 mutations in cutaneous malignant melanoma patients of Ashkenazi origin.阿什肯纳兹血统的皮肤恶性黑色素瘤患者中不存在始祖BRCA1和BRCA2突变。
Fam Cancer. 2009;8(1):29-32. doi: 10.1007/s10689-008-9206-8. Epub 2008 Aug 5.
2
Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer.BRCA1/2基因突变对侵袭性卵巢癌患者长期生存的影响:以色列全国卵巢癌研究
J Clin Oncol. 2008 Jan 1;26(1):20-5. doi: 10.1200/JCO.2007.11.6905.
3
The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer.乳腺癌家族登记处:一个用于乳腺癌遗传流行病学合作性跨国、跨学科和转化研究的基础设施。
Breast Cancer Res. 2004;6(4):R375-89. doi: 10.1186/bcr801. Epub 2004 May 19.
4
Frequency of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish patients with colorectal cancer.未选择的阿什肯纳兹犹太裔结直肠癌患者中BRCA1和BRCA2突变的频率。
J Natl Cancer Inst. 2004 Jan 7;96(1):68-70. doi: 10.1093/jnci/djh006.
5
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.由于BRCA1和BRCA2基因的遗传性突变导致的乳腺癌和卵巢癌风险。
Science. 2003 Oct 24;302(5645):643-6. doi: 10.1126/science.1088759.
6
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.在未根据家族史进行选择的病例系列中检测到的与BRCA1或BRCA2基因突变相关的乳腺癌和卵巢癌平均风险:22项研究的综合分析
Am J Hum Genet. 2003 May;72(5):1117-30. doi: 10.1086/375033. Epub 2003 Apr 3.
7
Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection.德系犹太人种群中疾病突变的地理分布支持了遗传漂变而非选择。
Am J Hum Genet. 2003 Apr;72(4):812-22. doi: 10.1086/373882. Epub 2003 Feb 24.
8
BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.对208名患有卵巢癌的阿什肯纳兹犹太女性进行BRCA1和BRCA2基因突变分析。
Am J Hum Genet. 2000 Apr;66(4):1259-72. doi: 10.1086/302853. Epub 2000 Mar 16.
9
BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer.双侧乳腺癌患者中的BRCA1和BRCA2始祖突变
Eur J Hum Genet. 1999 Oct-Nov;7(7):833-6. doi: 10.1038/sj.ejhg.5200371.
10
Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.未筛选的患乳腺癌的德系犹太女性中BRCA1和BRCA2基因突变的患病率及外显率
J Natl Cancer Inst. 1999 Jul 21;91(14):1241-7. doi: 10.1093/jnci/91.14.1241.

在巴西南部的阿什肯纳兹犹太裔女性中,BRCA1 中的 185delAG 和 5382insC 突变,以及 BRCA2 中的 6174delT 的发生率。

Prevalence of 185delAG and 5382insC mutations in BRCA1, and 6174delT in BRCA2 in women of Ashkenazi Jewish origin in southern Brazil.

机构信息

Banco de DNA/Tecido de Mama e Ovário, Centro de Pesquisas Experimentais, Hospital de Clínicas de Porto Alegre, RS, Brazil.

出版信息

Genet Mol Biol. 2012 Jul;35(3):599-602. doi: 10.1590/S1415-47572012000400009. Epub 2012 Aug 17.

DOI:10.1590/S1415-47572012000400009
PMID:23055798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3459409/
Abstract

Certain mutations in BRCA1 and BRCA2 genes are frequent in the Ashkenazi Jewish population. Several factors contribute to this increased frequency, including consanguineous marriages and an event known as a "bottleneck", which occurred in the past and caused a drastic reduction in the genetic variability of this population. Several studies were performed over the years in an attempt to elucidate the role of BRCA1 and BRCA2 genes in susceptibility to breast cancer. The aim of this study was to estimate the carrier frequency of certain common mutations in the BRCA1 (185delAG and 5382insC) and BRCA2 (6174delT) genes in an Ashkenazi Jewish population from Porto Alegre, Brazil. Molecular analyses were done by PCR followed by RFLP (ACRS). The carrier frequencies for BRCA1 185delAG and 5382insC were 0.78 and 0 respectively, and 0.4 for the BRCA2 6174deT mutation. These findings are similar to those of some prior studies but differ from others, possibly due to excluding individuals with a personal or family history of cancer. Our sample was drawn from the community group and included individuals with or without a family or personal history of cancer. Furthermore, increased dispersion among Ashkenazi subpopulations may be the result of strong genetic drift and/or admixture. It is therefore necessary to consider the effects of local admixture on the mismatch distributions of various Jewish populations.

摘要

BRCA1 和 BRCA2 基因中的某些突变在阿什肯纳兹犹太人中很常见。有几个因素导致了这种频率的增加,包括近亲结婚和过去发生的“瓶颈”事件,这导致了该人群遗传变异性的急剧减少。多年来,已经进行了几项研究,试图阐明 BRCA1 和 BRCA2 基因在乳腺癌易感性中的作用。本研究的目的是估计巴西阿雷格里港的阿什肯纳兹犹太人中 BRCA1(185delAG 和 5382insC)和 BRCA2(6174delT)基因中某些常见突变的携带频率。通过 PCR followed by RFLP(ACRS)进行分子分析。BRCA1 185delAG 和 5382insC 的携带频率分别为 0.78 和 0,BRCA2 6174deT 突变的携带频率为 0.4。这些发现与一些先前的研究相似,但与其他研究不同,这可能是由于排除了有个人或家族癌症史的个体。我们的样本来自社区群体,包括有或没有家族或个人癌症史的个体。此外,阿什肯纳兹亚人群体之间的分散增加可能是由于强烈的遗传漂变和/或混合。因此,有必要考虑当地混合对各种犹太人群体错配分布的影响。